V. Venturelli

Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension.

L. Zagato, P. Manunta, C. Lanzani, 2006, Journal of the American College of Cardiology.

Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription

M. Volpe, S. Rubattu, R. Stanzione, 2002, Peptides.

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

G. Lembo, M. Volpe, F. Cosentino, 2005, American Journal of Hypertension.

Endothelial Dysfunction and Stroke

M. Volpe, F. Cosentino, C. Savoia, 2001, Journal of cardiovascular pharmacology.

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries

C. Indolfi, M. Arca, L. De Luca, 2020, Cardiovascular therapeutics.

Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.

M. Volpe, S. Sciarretta, G. Tocci, 2007, American journal of hypertension.

Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

M. Volpe, S. Sciarretta, G. Tocci, 2007, Journal of hypertension.

Metabolic Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome

M. Volpe, S. Sciarretta, G. Tocci, 2007 .